West Pharmaceutical Services (WST)
SG&A Expense Growth
18.19%
Quarterly · Period ending:
WST SG&A Expense Growth
Latest reported18.19%period ending
Latest reported18.19%period ending
WST Quarterly SG&A Growth (QoQ) (0.00% → 18.19%)
Latest values, visible window
High-resolution chart · PNG
WST sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 18.191% | |
| -6.5728% | |
| 3.7001% | |
| 7.0907% | |
| 8.9773% | |
| 3.1653% | |
| 4.1514% | |
| -1.3253% | |
| -4.2676% | |
| -3.6667% | |
| 1.1236% | |
| 0.6787% | |
| 2.7907% | |
| 0.3501% | |
| 29.2609% | |
| -18.6503% | |
| -2.2782% | |
| -14.898% | |
| 6.6376% | |
| -0.863% | |
| 15.586% | |
| 5.1114% | |
| 6.4156% | |
| -5.0331% | |
| 5.1532% | |
| 4.058% | |
| 6.4815% | |
| -7.8236% | |
| 2.4781% | |
| 14.9079% | |
| -8.0123% | |
| -7.2857% | |
| 2.489% | |
| 14.5973% | |
| -4.7923% | |
| 2.1207% | |
| -0.487% | |
| 1.1494% | |
| 4.4597% | |
| -6.72% | |
| 7.5731% | |
| -6.891% | |
| 14.2857% | |
| -23.8494% | |
| 29.8913% | |
| -6.1224% | |
| 5% | |
| -2.6087% | |
| 1.9504% | |
| -6% | |
| 6.9519% | |
| -6.0302% | |
| 1.0152% | |
| 0.8532% | |
| 9.1248% | |
| -1.2868% | |
| 6.0429% | |
| 10.7991% | |
| 1.3129% | |
| -5.7732% | |
| -4.1502% | |
| 0.198% | |
| 12.4722% | |
| -1.9651% | |
| -1.7167% | |
| 2.6432% | |
| 2.4831% | |
| -1.7738% | |
| 5.1282% | |
| 16.5761% | |
| -11.3253% | |
| 1.467% | |
| 1.995% | |
| 1.0076% | |
| 5.305% | |
| -1.3089% | |
| 3.2432% | |
| -15.7175% | |
| 18.3288% | |
| 0.542% | |
| -2.8947% | |
| 17.284% | |
| 5.5375% | |
| -3.7618% | |
| 26.5873% | |
| 66.8874% | |
| -50.165% | |
| -1.6234% | |
| 6.2069% | |
| -9.375% | |
| 15.1079% | |
| 3.7313% | |
| 9.8361% | |
| 16.1905% | |
| 8.8083% | |
| -11.4679% | |
| 6.3415% | |
| 30.5732% | |
| -19.0722% | |
| 2.1053% |